Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NANOVAE in Knee Osteoarthritis
NCT06606561Phase 2Not yet recruiting
- Sponsor
- Novavita Laboratory
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of NANOVAE in knee osteoarthritis (OA), sponsored by Novavita Laboratory. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
NANOVAE
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06606561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06606561.